Characteristics of pyridoxine overdose neuropathy syndrome
- 1 July 1987
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 76 (1) , 8-11
- https://doi.org/10.1111/j.1600-0404.1987.tb03536.x
Abstract
A newly recognised neurotoxic syndrome due to pyridoxine (B6) overdose is described. It is the largest series of B6 intoxication hitherto reported. A raised serum B6 level was present in 172 women of whom 60% had neurological symptoms, which disappeared when B6 was withdrawn and reappeared in 4 cases when B6 was restarted. The mean dose of B6 in the 103 women with neurological symptoms was 117 ± 92 mgs, compared with 116.2 ± 66 mgs in the control group. There was a significant difference (P < 0.01) in the average duration of ingestion of B6 in the neurotoxic group of 2.9 ± 1.9 years compared with 1.6 ± 2.1 years in controls. The symptoms were paraesthesia, hyperaesthesia, bone pains, muscle weakness, numbness and fasciculation, most marked on the extremeties and predominantly bilateral unless there was a history of previous trauma to the limb. These women were taking a lower dose of B6 than previously described (1,2), which may account for the complete recovery within 6 months of stopping B6.Keywords
This publication has 5 references indexed in Scilit:
- Sensory neuropathy with low‐dose pyridoxineNeurology, 1985
- Controlled Trial of Pyridoxine in the Premenstrual SyndromeJournal of International Medical Research, 1985
- Pyridoxine MegavitaminosisJournal of Neuropathology and Experimental Neurology, 1985
- Sensory Neuropathy from Pyridoxine AbuseNew England Journal of Medicine, 1983
- A simple enzymic assay for pyridoxal phosphateAnalytical Biochemistry, 1970